Compounds and methods for inhibiting viral replication and methods of treating and preventing flaviviral infections

The present disclosure relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof. The present disclosure further relates to methods of inhibiting viral replication including contacting one or more cells that have been infected with a virus with an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein the virus comprises a flavivirus. Also disclosed is a method of treating and/or preventing a flavivirus infection and/or a condition resulting from a flavivirus infection including administering an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof under conditions effective to treat and/or prevent a flavivirus infection and/or a condition resulting from a flavivirus infection..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 26. Sept. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

LI HONGMIN [VerfasserIn]
LI ZHONG [VerfasserIn]
ZHOU JIA [VerfasserIn]
XU JIMIN [VerfasserIn]
ZHANG QING-YU [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C07C: Acyclic or carbocyclic compounds (macromolecular co (...)
C07D: Heterocyclic compounds (macromolecular compounds c0 (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-09-26, Last update posted on www.tib.eu: 2023-10-19, Last updated: 2023-10-27

Patentnummer:

US11767303

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA018229948